ARCH Venture Management, LLC Diversified Active

Location: Chicago, IL

CIK: 0001274403 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value: $206M (100.0% shares, 0.0% debt)

Holdings (9)

BEAM BEAM THERAPEUTICS INC. 43.0%

Value $88.67M Shares 4,540,132 Est. Cost $24.56 Unrealized +6.7%

MAZE MAZE THERAPEUTICS, INC. 22.0%

Value $45.36M Shares 4,120,053 Est. Cost $12.04 Unrealized 0.0%

RAPP RAPPORT THERAPEUTICS, INC. 18.2%

Value $37.55M Shares 3,728,738 Est. Cost $23.15 Unrealized -43.9%

ERAS ERASCA, INC. 7.3%

Value $15.15M Shares 11,055,554 Est. Cost $17.12 Unrealized -90.0%

— VERVE THERAPEUTICS, INC. 4.4%

Value $9.12M Shares 2,008,809 Est. Cost $36.87 Unrealized —

GOSS GOSSAMER BIO, INC. 4.3%

Value $8.781M Shares 8,055,916 Est. Cost $1.15 Unrealized +0.3%

— UNITY BIOTECHNOLOGY, INC. 0.5%

Value $1.045M Shares 1,004,817 Est. Cost $0.40 Unrealized —

QTTB Q32 BIO INC. 0.3%

Value $532K Shares 320,482 Est. Cost $13.78 Unrealized -80.5%

— CERO THERAPEUTICS HOLDINGS, INC. 0.0%

Value $16,134 Shares 22,102 Est. Cost $0.73 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BEAM	BEAM THERAPEUTICS INC.	4,540,132	$88.67M	43.0%	$24.56	+6.7%	COM	07373V105
MAZE	MAZE THERAPEUTICS, INC.	4,120,053	$45.36M	22.0%	$12.04	0.0%	COM	578784100
RAPP	RAPPORT THERAPEUTICS, INC.	3,728,738	$37.55M	18.2%	$23.15	-43.9%	COM	75383L102
ERAS	ERASCA, INC.	11,055,554	$15.15M	7.3%	$17.12	-90.0%	COM	29479A108
—	VERVE THERAPEUTICS, INC.	2,008,809	$9.12M	4.4%	$36.87	—	COM	92539P101
GOSS	GOSSAMER BIO, INC.	8,055,916	$8.781M	4.3%	$1.15	+0.3%	COM	38341P102
—	UNITY BIOTECHNOLOGY, INC.	1,004,817	$1.045M	0.5%	$0.40	—	COM NEW	91381U200
QTTB	Q32 BIO INC.	320,482	$532K	0.3%	$13.78	-80.5%	COM	746964105
—	CERO THERAPEUTICS HOLDINGS, INC.	22,102	$16,134	0.0%	$0.73	—	COM NEW	71902K303